Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Allergen
Sort By
Newest First
1 / 1
1 / 1
Response
Allergan Responds to Public Shareholder Letter
Allergan, plc
PR-M02-19-NI-047
Feb 21, 2019
Collaboration
Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101
Allergan, plc
PR-M08-18-NI-062
Aug 17, 2018
